Bank of New York Mellon’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
BOCH
N
FIA
Bank of New York Mellon's SGMT Position: Q2 2026 in Review
Bank of New York Mellon opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 200,648 shares worth $1.55M. The stake represents ﹤0.01% of the portfolio and ranks #3102 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in SGMT as recently as Q1 2024.
Bank of New York Mellon first reported a position in SGMT in Q3 2023 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.
- Bank of New York Mellon held 200,648 shares of Sagimet Biosciences worth $1.55M as of Q2 2026.
- Sagimet Biosciences was a new Bank of New York Mellon position in Q2 2026.
- Sagimet Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3102 holding.
- Bank of New York Mellon first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 4 quarters since.
- 49 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.